Physical Models and Simpler Dosimetric Descriptors of Radiation Late Toxicity

Seminars in Radiation Oncology

Volumn 17, Issue 2, 2007, Pages 108-120

 

^a Spring)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMEN; ARTICLE; CALCULATION; CANCER RADIOTHERAPY; DOSIMETRY; EVALUATION; HEAD; HEART INJURY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER INJURY; LUNG TOXICITY; MATHEMATICAL ANALYSIS; NECK; NONHUMAN; NORMAL TISSUE COMPLICATION PROBABILITY; PAROTID GLAND; PELVIS; PHYSICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIATION PNEUMONIA; RADIOSENSITIVITY; RECTUM INJURY; SPINAL CORD INJURY; THORAX; TREATMENT PLANNING;

EID: 33947502318     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2006.11.007     Document Type: Article

References (114)

1. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
2. Ben-Josef E., and Lawrence T.S. Radiotherapy for unresectable hepatic malignancies. Semin Radiat Oncol 15 (2005) 273-278
3. Lawrence T.S. The role of radiation in liver cancer. Clin Adv Hematol Oncol 4 (2006) 113-115
4. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
5. Ten Haken R.K., and Lawrence T.S. The clinical application of intensity modulated radiation therapy. Semin Radiat Oncol 16 (2006) 224-231
6. Kong F.M., Ten Haken R., Eisbruch A., et al. Non-small cell lung cancer therapy-related pulmonary toxicity: An update on radiation pneumonitis and fibrosis. Semin Oncol 32 (2005) S42-S54
7. Ten Haken R.K., and Kessler M.L. 3-D CRT Plan Evaluation. In: Purdy J.A., Grant III W.H., Palta J.R., Butler E.B., and Perez C.A. (Eds). 3-D Conformal and Intensity Modulated Radiation Therapy 16 (2001), Advanced Medical Publishing, Madison WI 224-231
8. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8 (1985) S13-S19
9. Kallman P., Agren A., and Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 62 (1992) 249-262
10. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
11. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
12. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
13. Kutcher G.J., Burman C., Brewster L., et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 21 (1991) 137-146
14. Schultheiss T.E., Orton C.G., and Peck R.A. Models in radiotherapy: volume effects. Med Phys 10 (1983) 410-415
15. Niemierko A., and Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol 20 (1991) 166-176
16. Jackson A., Kutcher G.J., and Yorke E.D. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 20 (1993) 613-625
17. Yorke E.D., Kutcher G.J., Jackson A., et al. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 26 (1993) 226-237
18. Niemierko A., and Goitein M. Modeling of normal tissue response to radiation: The critical volume model. Int J Radiat Oncol Biol Phys 25 (1993) 135-145
19. Thames H.D., Zhang M., Tucker S.L., et al. Cluster models of dose-volume effects. Int J Radiat Oncol Biol Phys 59 (2004) 1491-1504
20. Yorke E.D. Modeling the effects of inhomogeneous dose distributions in normal tissues. Semin Radiat Oncol 11 (2001) 197-209
21. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
22. Ten Haken R.K. Partial organ irradiation; Introduction. Semin Radiat Oncol 11 (2001) 181-183
23. Schultheiss T.E. The controversies and pitfalls in modeling normal tissue radiation injury/damage. Semin Radiat Oncol 11 (2001) 210-214
24. Deasy J.O., Niemierko A., Herbert D., et al. Methodological issues in radiation dose-volume outcome analyses: Summary of a joint AAPM/NIH workshop. Med Phys 29 (2002) 2109-2127
25. Denis F., Garaud P., Bardet E., et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: Comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 55 (2003) 93-98
26. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
27. Blanco A.I., Chao K.S., El Naqa I., et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1055-1069
28. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
29. Cassatt D.R., Fazenbaker C.A., Bachy C.M., et al. Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy. Semin Radiat Oncol 12 (2002) 97-102
30. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
31. Jellema A.P., Doornaert P., Slotman B.J., et al. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 (2005) 164-171
32. Roesink J.M., Schipper M., Busschers W., et al. A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: Implications for future trials. Int J Radiat Oncol Biol Phys 63 (2005) 1006-1009
33. Braam P.M., Roesink J.M., Moerland M.A., et al. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 659-664
34. Eisbruch A., Rhodus N., Rosenthal D., et al. How should we measure and report radiotherapy-induced xerostomia?. Semin Radiat Oncol 13 (2003) 226-234
35. Trott K.R., Herrmann T., and Kasper M. Target cells in radiation pneumopathy. Int J Radiat Oncol Biol Phys 58 (2004) 463-469
36. Eisbruch A. Reducing radiation-induced xerostomia with highly conformal radiotherapy techniques. J Support Oncol 3 (2005) 201-202
37. Willner J., Jost A., Baier K., et al. A little to a lot or a lot to a little?. An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 179 (2003) 548-556
38. Rodrigues G., Lock M., D'Souza D., et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-A systematic review. Radiother Oncol 71 (2004) 127-138
39. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 67 (2003) 275-283
40. Seppenwoolde Y., and Lebesque J.V. Partial irradiation of the lung. Semin Radiat Oncol 11 (2001) 247-258
41. Marks L.B., Munley M.T., Bentel G.C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39 (1997) 563-570
42. Armstrong J., Raben A., Zelefsky M., et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 44 (1997) 17-22
43. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28 (1994) 575-581
44. Gagliardi G., Bjohle J., Lax I., et al. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 46 (2000) 373-381
45. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
46. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
47. Claude L., Perol D., Ginestet C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 71 (2004) 175-181
48. Lind P.A., Wennberg B., Gagliardi G., et al. ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys 64 (2006) 765-770
49. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235 (2005) 208-215
50. Lind P.A., Marks L.B., Hollis D., et al. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54 (2002) 340-347
51. Tsujino K., Hirota S., Kotani Y., et al. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys 64 (2006) 1100-1105
52. Hope A.J., Lindsay P.E., El Naqa I., et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65 (2006) 112-124
53. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33 (1995) 455-460
54. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
55. Liao Z., Wang S.L., Wei X., et al. Analysis of clinical and dosimetric factors associated with radiation pneumonitis (RP) in patients with non-small cell lung cancer (NSCLC) treated with concurrent chemotherapy (ConChT) and three dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 63 (2005) S41
56. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
57. Belderbos J.S., De Jaeger K., Heemsbergen W.D., et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66 (2003) 119-126
58. Tucker S.L., Liao Z.X., and Travis E.L. Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 38 (1997) 1055-1066
59. Yamada M., Kudoh S., Hirata K., et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 34 (1998) 71-75
60. Allen A.M., Czerminska M., Janne P.A., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65 (2006) 640-645
61. Gagliardi G., Lax I., Soderstrom S., et al. Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. Radiother Oncol 46 (1998) 63-71
62. Martel M.K., Sahijdak W.M., Ten Haken R.K., et al. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 40 (1998) 155-161
63. Gagliardi G., Lax I., Ottolenghi A., et al. Long-term cardiac mortality after radiotherapy of breast cancer-Application of the relative seriality model. Br J Radiol 69 (1996) 839-846
64. Eriksson F., Gagliardi G., Liedberg A., et al. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: Analysis with the relative seriality model. Radiother Oncol 55 (2000) 153-162
65. Hancock S.L., Tucker M.A., and Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993) 1949-1955
66. Gyenes G., Rutqvist L.E., Liedberg A., et al. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 48 (1998) 185-190
67. Carr Z.A., Land C.E., Kleinerman R.A., et al. Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys 61 (2005) 842-850
68. Hurkmans C.W., Cho B.C., Damen E., et al. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 62 (2002) 163-171
69. Gagliardi G., Lax I., and Rutqvist L.E. Partial irradiation of the heart. Semin Radiat Oncol 11 (2001) 224-233
70. Prosnitz R.G., Chen Y.H., and Marks L.B. Cardiac toxicity following thoracic radiation. Semin Oncol 32 (2005) S71-S80
71. Fein D.A., Marcus Jr. R.B., Parsons J.T., et al. Lhermitte's sign: incidence and treatment variables influencing risk after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys 27 (1993) 1029-1033
72. Alfonso E.R., De Gregorio M.A., Mateo P., et al. Radiation myelopathy in over-irradiated patients: MR imaging findings. Eur Radiol 7 (1997) 400-404
73. Rampling R., and Symonds P. Radiation myelopathy. Curr Opin Neurol 11 (1998) 627-632
74. Schultheiss T.E. Spinal cord radiation tolerance. Int J Radiat Oncol Biol Phys 30 (1994) 735-736
75. Schultheiss T.E., Stephens L.C., Jiang G.L., et al. Radiation myelopathy in primates treated with conventional fractionation. Int J Radiat Oncol Biol Phys 19 (1990) 935-940
76. Macbeth F.R., Wheldon T.E., Girling D.J., et al., The Medical Research Council Lung Cancer Working Party. Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. Clin Oncol (R Coll Radiol) 8 (1996) 176-181
77. Jeremic B., Djuric L., and Mijatovic L. Incidence of radiation myelitis of the cervical spinal cord at doses of 5500 cGy or greater. Cancer 68 (1991) 2138-2141
78. Philippens M.E., Pop L.A., Visser A.G., et al. Dose-volume effects in rat thoracolumbar spinal cord: An evaluation of NTCP models. Int J Radiat Oncol Biol Phys 60 (2004) 578-590
79. Phillips T.L., and Buschke F. Radiation tolerance of the thoracic spinal cord. Am J Roentgenol Radium Ther Nucl Med 105 (1969) 659-664
80. Abbatucci J.S., Delozier T., Quint R., et al. Radiation myelopathy of the cervical spinal cord: Time, dose and volume factors. Int J Radiat Oncol Biol Phys 4 (1978) 239-248
81. Kim Y.H., and Fayos J.V. Radiation tolerance of the cervical spinal cord. Radiology 139 (1981) 473-478
82. McCunniff A.J., and Liang M.J. Radiation tolerance of the cervical spinal cord. Int J Radiat Oncol Biol Phys 16 (1989) 675-678
83. Marcus Jr. R.B., and Million R.R. The incidence of myelitis after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys 19 (1990) 3-8
84. Jeremic B., Shibamoto Y., Milicic B., et al. Absence of thoracic radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for stage III nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 40 (1998) 343-346
85. van der Kogel A.J. Dose-volume effects in the spinal cord. Radiother Oncol 29 (1993) 105-109
86. Shirato H., Mizuta M., and Miyasaka K. A mathematical model of the volume effect which postulates cell migration from unirradiated tissues. Radiother Oncol 35 (1995) 227-231
87. Marucci L., Niemierko A., Liebsch N.J., et al. Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis. Int J Radiat Oncol Biol Phys 59 (2004) 551-555
88. Bloss J.D., DiSaia P.J., Mannel R.S., et al. Radiation myelitis: A complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of the uterine cervix. Gynecol Oncol 43 (1991) 305-308
89. Gatcombe H., Lawson J., Phuphanich S., et al. Treatment related myelitis in hodgkin's lymphoma following stem cell transplant, chemotherapy and radiation: a case report and review of the literature. J Neurooncol 79 3 (2006) 293-298
90. Raney B., Tefft M., Heyn R., et al. Ascending myelitis after intensive chemotherapy and radiation therapy in children with cranial parameningeal sarcoma. Cancer 69 (1992) 1498-1506
91. Nieder C., Grosu A.L., Andratschke N.H., et al. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. Int J Radiat Oncol Biol Phys 61 (2005) 851-855
92. Cheng J.C., Chuang V.P., Cheng S.H., et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 47 (2000) 435-442
93. Dawson L.A., and Ten Haken R.K. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15 (2005) 279-283
94. Kutcher G.J., and Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 16 (1989) 1623-1630
95. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
96. Xu Z.Y., Liang S.X., Zhu J., et al. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 189-195
97. Dawson L.A., Lawrence T.S., and Ten Haken R.K. In response to Dr. Tome and Dr. Fenwick. Int J Radiat Oncol Biol Phys 58 (2004) 1319-1320
98. Liang S.X., Zhu X.D., Xu Z.Y., et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65 (2006) 426-434
99. Cheng J.C., Liu H.S., Wu J.K., et al. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease. Int J Radiat Oncol Biol Phys 62 (2005) 1150-1156
100. Goldner G., Tomicek B., and Becker G. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: Results of a prospective multicenter study of 166 patients. Int J Radiat Oncol Biol Phys 67 1 (2007) 78-83
101. van Lin E.N., Kristinsson J., Philippens M.E., et al. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys (2006) Dec 7; [Epub ahead of print]
102. Gilinsky N.H., Burns D.G., Barbezat G.O., et al. The natural history of radiation-induced proctosigmoiditis: an analysis of 88 patients. Q J Med 52 (1983) 40-53
103. Dale E., Olsen D.R., and Fossa S.D. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys 43 (1999) 385-391
104. Rancati T., Fiorino C., Gagliardi G., et al. Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 73 (2004) 21-32
105. Jackson A. Partial irradiation of the rectum. Semin Radiat Oncol 11 (2001) 215-223
106. Sandler H.M., McLaughlin P.W., Ten Haken R.K., et al. Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients. Int J Radiat Oncol Biol Phys 33 (1995) 797-801
107. Benk V.A., Adams J.A., Shipley W.U., et al. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys 26 (1993) 551-557
108. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
109. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
110. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
111. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 47 (2000) 103-113
112. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
113. Fellin G., Valdagni R., Rancati T., et al. Predictors of late rectal toxicity in high-dose 3D CRT for prostate cancer: Preliminary results from a prospective multicentric study performed by the AIRO National Working Group on Prostate Irradiation. 2006 Prostate Cancer Symposium 125 (2006)
114. Akimoto T., Muramatsu H., Takahashi M., et al. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding. Int J Radiat Oncol Biol Phys 60 (2004) 1033-1039